Rezolute, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)

9 Months Ended

Mar. 31, 2020

The calculation of net loss attributable to common stockholders for the three and nine months ended March 31, 2019 reflects the BCF related to the issuance of Series AA Preferred Stock to the New Investors discussed in Note 5, as follows:


	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2020		2019		2020		2019
Net loss	$	(5,040)	$	(19,772)	$	(16,786)	$	(27,299)
Beneficial conversion feature		—		(2,273)		—		(2,273)
Net loss attributable to common stockholders	$	(5,040)	$	(22,045)	$	(16,786)	$	(29,572)

Summary of potential common stock equivalents outstanding were excluded from the computation of diluted net loss per share

As of March 31, 2020 and 2019, the following outstanding potential common stock equivalents were excluded from the computation of diluted net loss per share since the impact of inclusion was anti-dilutive (in thousands):


	2020	2019

Stock options	48,155	16,868
Warrants	30,915	46,389
Series AA Preferred Stock	—	148,524
Total	79,070	211,781